Lymphoma, T-Cell, Cutaneous

"Lymphoma, T-Cell, Cutaneous" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A group of lymphomas exhibiting clonal expansion of malignant T-lymphocytes arrested at varying stages of differentiation as well as malignant infiltration of the skin. MYCOSIS FUNGOIDES; SEZARY SYNDROME; LYMPHOMATOID PAPULOSIS; and PRIMARY CUTANEOUS ANAPLASTIC LARGE CELL LYMPHOMA are the best characterized of these disorders.

Descriptor ID	D016410
MeSH Number(s)	C04.557.386.480.750.800 C15.604.515.569.480.750.800 C20.683.515.761.480.750.800
Concept/Terms	Lymphoma, T-Cell, Cutaneous Lymphoma, T-Cell, Cutaneous T-Cell Lymphoma, Cutaneous T Cell Lymphoma, Cutaneous Cutaneous T-Cell Lymphoma Cutaneous T Cell Lymphoma Cutaneous T-Cell Lymphomas Lymphoma, Cutaneous T-Cell Lymphomas, Cutaneous T-Cell T-Cell Lymphomas, Cutaneous Lymphoma, T Cell, Cutaneous Granulomatous Slack Skin Granulomatous Slack Skin Slack Skin, Granulomatous

Below are MeSH descriptors whose meaning is more general than "Lymphoma, T-Cell, Cutaneous".

Diseases [C]
Neoplasms [C04]
Neoplasms by Histologic Type [C04.557]
Lymphoma [C04.557.386]
Lymphoma, Non-Hodgkin [C04.557.386.480]
Lymphoma, T-Cell [C04.557.386.480.750]
Lymphoma, T-Cell, Cutaneous [C04.557.386.480.750.800]
Hemic and Lymphatic Diseases [C15]
Lymphatic Diseases [C15.604]
Lymphoproliferative Disorders [C15.604.515]
Lymphoma [C15.604.515.569]
Lymphoma, Non-Hodgkin [C15.604.515.569.480]
Lymphoma, T-Cell [C15.604.515.569.480.750]
Lymphoma, T-Cell, Cutaneous [C15.604.515.569.480.750.800]
Immune System Diseases [C20]
Immunoproliferative Disorders [C20.683]
Lymphoproliferative Disorders [C20.683.515]
Lymphoma [C20.683.515.761]
Lymphoma, Non-Hodgkin [C20.683.515.761.480]
Lymphoma, T-Cell [C20.683.515.761.480.750]
Lymphoma, T-Cell, Cutaneous [C20.683.515.761.480.750.800]

Below are MeSH descriptors whose meaning is related to "Lymphoma, T-Cell, Cutaneous".

Below are MeSH descriptors whose meaning is more specific than "Lymphoma, T-Cell, Cutaneous".

Lymphoma, T-Cell, Cutaneous
Lymphoma, Primary Cutaneous Anaplastic Large Cell
Lymphomatoid Papulosis
Mycosis Fungoides
Sezary Syndrome

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Lymphoma, T-Cell, Cutaneous" by people in this website by year, and whether "Lymphoma, T-Cell, Cutaneous" was a major or minor topic of these publications.

Bar chart showing 18 publications over 11 distinct years, with a maximum of 3 publications in 2010 and 2016

To see the data from this visualization as text, click here.

Year	Major Topic	Total
2003	1	1
2006	1	1
2007	2	2
2009	1	1
2010	3	3
2011	2	2
2013	2	2
2015	1	1
2016	3	3
2017	1	1
2019	1	1

Below are the most recent publications written about "Lymphoma, T-Cell, Cutaneous" by people in Profiles.

Alpdogan O, Kartan S, Johnson W, Sokol K, Porcu P. Systemic therapy of cutaneous T-cell lymphoma (CTCL). Chin Clin Oncol. 2019 Feb; 8(1):10.

View in: PubMed
Mishra A, Porcu P. Expanding and expounding the genomic map of CTCL. Blood. 2017 09 21; 130(12):1389-1390.

View in: PubMed
Virmani P, Hwang SH, Hastings JG, Haverkos BM, Kohnken B, Gru AA, Mishra A, Fabbro SK, Horwitz SM, Porcu P. Systemic therapy for cutaneous T-cell lymphoma: who, when, what, and why? Expert Rev Hematol. 2017 Feb; 10(2):111-121.

View in: PubMed
Kohnken R, Fabbro S, Hastings J, Porcu P, Mishra A. Sézary Syndrome: Clinical and Biological Aspects. Curr Hematol Malig Rep. 2016 12; 11(6):468-479.

View in: PubMed
Mishra A, La Perle K, Kwiatkowski S, Sullivan LA, Sams GH, Johns J, Curphey DP, Wen J, McConnell K, Qi J, Wong H, Russo G, Zhang J, Marcucci G, Bradner JE, Porcu P, Caligiuri MA. Mechanism, Consequences, and Therapeutic Targeting of Abnormal IL15 Signaling in Cutaneous T-cell Lymphoma. Cancer Discov. 2016 Sep; 6(9):986-1005.

View in: PubMed
Kaffenberger B, Haverkos B, Tyler K, Wong HK, Porcu P, Gru AA. Extranodal Marginal Zone Lymphoma-like Presentations of Angioimmunoblastic T-Cell Lymphoma: A T-Cell Lymphoma Masquerading as a B-Cell Lymphoproliferative Disorder. Am J Dermatopathol. 2015 Aug; 37(8):604-13.

View in: PubMed
McGirt LY, Adams CM, Baerenwald DA, Zwerner JP, Zic JA, Eischen CM. miR-223 regulates cell growth and targets proto-oncogenes in mycosis fungoides/cutaneous T-cell lymphoma. J Invest Dermatol. 2014 Apr; 134(4):1101-7.

View in: PubMed
Wells CE, Bhaskara S, Stengel KR, Zhao Y, Sirbu B, Chagot B, Cortez D, Khabele D, Chazin WJ, Cooper A, Jacques V, Rusche J, Eischen CM, McGirt LY, Hiebert SW. Inhibition of histone deacetylase 3 causes replication stress in cutaneous T cell lymphoma. PLoS One. 2013; 8(7):e68915.

View in: PubMed
Mishra A, Porcu P. Early CTCL diagnosis, a (miR)age no more? Blood. 2011 Nov 24; 118(22):5717-8.

View in: PubMed
Querfeld C, Kuzel TM, Kim YH, Porcu P, Duvic M, Musiek A, Rook AH, Mark LA, Pinter-Brown L, Hamid O, Lin B, Bian Y, Boye M, Day JM, Rosen ST. Multicenter phase II trial of enzastaurin in patients with relapsed or refractory advanced cutaneous T-cell lymphoma. Leuk Lymphoma. 2011 Aug; 52(8):1474-80.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement